Neprilysin Inhibitor Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Neprilysin Inhibitor
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Torrent | SACUBITRIL AND VALSARTAN | sacubitril; valsartan | TABLET;ORAL | 213604-001 | Aug 22, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Alembic | SACUBITRIL AND VALSARTAN | sacubitril; valsartan | TABLET;ORAL | 213682-003 | May 28, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Torrent | SACUBITRIL AND VALSARTAN | sacubitril; valsartan | TABLET;ORAL | 213604-002 | Aug 22, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Torrent | SACUBITRIL AND VALSARTAN | sacubitril; valsartan | TABLET;ORAL | 213604-003 | Aug 22, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Laurus | SACUBITRIL AND VALSARTAN | sacubitril; valsartan | TABLET;ORAL | 213676-001 | May 28, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Laurus | SACUBITRIL AND VALSARTAN | sacubitril; valsartan | TABLET;ORAL | 213676-002 | May 28, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
